KDIGO. Clinical practice guideline update on diagnosis, evaluation, prevention and treatment of CKD-MBD, 2016.

• PubMed
KDIGO. Clinical practice guideline update on diagnosis, evaluation, prevention and treatment of CKD-MBD, 2016.)| false
• Search Google Scholar
• Export Citation

Block GA, et al.. Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: Two randomized controlled trials. JAMA 2017; 317:146–155.

• PubMed
Block GA, . Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: Two randomized controlled trials. JAMA 2017; 317:146–155.)| false
• Search Google Scholar
• Export Citation

Parfrey PS, et al.. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet. J Clin Endocrinol Metab 2013; 98:4834–4844.

• PubMed
Parfrey PS, . The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet. J Clin Endocrinol Metab 2013; 98:4834–4844.)| false
• Search Google Scholar
• Export Citation

Chertow GM, et al.. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 2012; 367:2482–2494.

• PubMed
Chertow GM, . Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 2012; 367:2482–2494.)| false
• Search Google Scholar
• Export Citation

Parfrey PS, et al.. The effects of cinacalcet in older and younger patients on hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Clin J Am Soc Nephrol 2015; 10:791–799.

• PubMed
Parfrey PS, . The effects of cinacalcet in older and younger patients on hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Clin J Am Soc Nephrol 2015; 10:791–799.)| false
• Search Google Scholar
• Export Citation

Parfrey PS, et al.. Lessons learned from EVOLVE for planning of future randomized trials in patients on dialysis. Clin J Am Soc Nephrol 2016; 11:539–546.

• PubMed
Parfrey PS, . Lessons learned from EVOLVE for planning of future randomized trials in patients on dialysis. Clin J Am Soc Nephrol 2016; 11:539–546.)| false
• Search Google Scholar
• Export Citation

Moe SM, et al.. Effects of cinacalcet on fracture events in patients receiving hemodialysis: The EVOLVE trial. J Am Soc Nephrol 2015; 26:1466–1475.

• PubMed
Moe SM, . Effects of cinacalcet on fracture events in patients receiving hemodialysis: The EVOLVE trial. J Am Soc Nephrol 2015; 26:1466–1475.)| false
• Search Google Scholar
• Export Citation

Floege J, et al.. The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: The EVOLVE trial. Clin J Am Soc Nephrol 2015; 10:800–807.

• PubMed
Floege J, . The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: The EVOLVE trial. Clin J Am Soc Nephrol 2015; 10:800–807.)| false
• Search Google Scholar
• Export Citation

Bover J, et al.. Clinical and practical use of calcimimetics in dialyisis patients with secondary hyperparathyroidism. Clin J Am Soc Nephrol 2016; 11:161–174.

• PubMed
Bover J, . Clinical and practical use of calcimimetics in dialyisis patients with secondary hyperparathyroidism. Clin J Am Soc Nephrol 2016; 11:161–174.)| false
• Search Google Scholar
• Export Citation

Belozeroff V, et al.. Economic evaluation of cinacalcet in the United States: The EVOLVE trial. Value Health 2015; 18:1079–1087.

• PubMed
Belozeroff V, . Economic evaluation of cinacalcet in the United States: The EVOLVE trial. Value Health 2015; 18:1079–1087.)| false
• Search Google Scholar
• Export Citation